The global pharmaceutical industry relies heavily on a robust network of chemical suppliers to provide essential building blocks for drug discovery and manufacturing. For companies involved in advanced organic synthesis and the development of new therapeutics, accessing high-quality pharmaceutical intermediates is a cornerstone of their operations. In this context, China has emerged as a dominant force, offering a vast array of chemical products, including specialized compounds like (Butoxycarbonylamino)cyclohexanecarboxylic Acid (CAS 222530-33-8). This article highlights the significance of sourcing such vital materials from reputable Chinese manufacturers and the advantages this partnership brings, including competitive pricing and guaranteed quality.

Understanding the Importance of CAS 222530-33-8

(Butoxycarbonylamino)cyclohexanecarboxylic Acid, with its molecular formula C12H21NO4, is a sophisticated organic molecule primarily utilized as a pharmaceutical intermediate. Its unique structure, featuring a protected amino group and a carboxylic acid functionality on a cyclohexane ring, makes it invaluable in peptide synthesis and the creation of complex drug molecules. The tert-butoxycarbonyl (Boc) protecting group is particularly important in controlled chemical reactions, ensuring that specific parts of the molecule react as intended. For researchers and chemists, the ability to reliably buy this compound at high purity levels (typically 99% or higher) is critical for ensuring the success and reproducibility of their experiments and production processes. The common melting point range of 143-147℃ also serves as an important quality indicator.

The Chinese Advantage: Quality, Price, and Reliability

When seeking to purchase (Butoxycarbonylamino)cyclohexanecarboxylic Acid, prospective buyers often look towards China due to the country's advanced chemical manufacturing capabilities. Leading Chinese suppliers and manufacturers are equipped with state-of-the-art facilities and adhere to international quality standards. This allows them to produce intermediates like CAS 222530-33-8 consistently and at scale, often at a more attractive price compared to suppliers in other regions. Furthermore, companies like NINGBO INNO PHARMCHEM CO.,LTD. prioritize customer satisfaction, offering comprehensive support, including technical data, safety information, and timely delivery. Engaging with these manufacturers facilitates a streamlined procurement process, reducing lead times and ensuring a stable supply chain for critical research and development projects.

Applications in Pharmaceutical R&D

The primary application of (Butoxycarbonylamino)cyclohexanecarboxylic Acid lies in its role as a key intermediate for solid-phase peptide synthesis (SPPS). It's also an essential component in the synthesis of various drug intermediates, particularly where a protected amino group needs to be incorporated into a complex molecular structure. Its utility extends to research laboratories focused on creating novel APIs, peptidomimetics, and other advanced chemical entities. As the pharmaceutical industry continues to innovate, the demand for versatile and high-purity building blocks like CAS 222530-33-8 will only increase, further solidifying the importance of reliable international suppliers.

Conclusion

For pharmaceutical companies and research institutions, identifying and partnering with dependable Chinese manufacturers for intermediates such as (Butoxycarbonylamino)cyclohexanecarboxylic Acid (CAS 222530-33-8) is a strategic imperative. It ensures access to high-quality materials, competitive pricing, and a stable supply chain, all vital for successful drug development. We encourage you to explore the offerings from experienced suppliers in China and to consider the benefits of working with a dedicated partner for your chemical sourcing needs.